AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2019
Nov 14, 2019
35599_dirs_2019-11-14_2a5fbc11-1a7c-4d09-94d7-0d2f86e524cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2019-11-13
Reporting Person: Cook Jodi A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-13 | Stock Option (right to buy) | $5.40 | A | 20000 | Acquired | 2029-11-13 | Common Shares (20000) | Direct |
Footnotes
F1: On November 13, 2019, Jodi Cook was granted an incentive stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan. 100% of the shares under this option were fully vested on the date of grant
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20